<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">32675964</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>09</Month>
        <Day>28</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Print">0899-8280</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>33</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Jul</Month>
            </PubDate>
          </JournalIssue>
          <Title>Proceedings (Baylor University. Medical Center)</Title>
          <ISOAbbreviation>Proc (Bayl Univ Med Cent)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The antisynthetase syndrome.</ArticleTitle>
        <Pagination>
          <StartPage>401</StartPage>
          <EndPage>403</EndPage>
          <MedlinePgn>401-403</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/08998280.2020.1764818</ELocationID>
        <Abstract>
          <AbstractText>Antisynthetase syndrome is an autoimmune disease affecting multiple organ systems that was first described as a triad of polymyositis, interstitial lung disease, and the presence of autoantibodies to aminoacyl-transfer ribonucleic acid synthetases. We describe a patient who developed respiratory symptoms following fume exposures. Following a prednisone taper for presumed hypersensitivity pneumonitis, he developed extrapulmonary symptoms suspicious for an autoimmune process discovered to be antisynthetase-associated interstitial lung disease and myositis. This case demonstrates the importance of avoiding anchoring to minimize morbidity and potentially mortality.</AbstractText>
          <CopyrightInformation>Copyright © 2020 Baylor University Medical Center.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Robinson</LastName>
            <ForeName>Drew</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Baylor Scott &amp; White Medical Center - TempleTempleTexas.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Scholz</LastName>
            <ForeName>Beth</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology, Baylor Scott &amp; White Medical Center - TempleTempleTexas.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>05</Month>
          <Day>18</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Proc (Bayl Univ Med Cent)</MedlineTA>
        <NlmUniqueID>9302033</NlmUniqueID>
        <ISSNLinking>0899-8280</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Antisynthetase syndrome</Keyword>
        <Keyword MajorTopicYN="N">hypersensitivity pneumonitis</Keyword>
        <Keyword MajorTopicYN="N">interstitial lung disease</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>3</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>4</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>4</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>7</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>7</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>7</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32675964</ArticleId>
        <ArticleId IdType="pmc">PMC7340408</ArticleId>
        <ArticleId IdType="doi">10.1080/08998280.2020.1764818</ArticleId>
        <ArticleId IdType="pii">1764818</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Gallay L, Gayed C, Hervier B. Antisynthetase syndrome pathogenesis: knowledge and uncertainties. Curr Opin Rheumatol. 2018;30(6):664–673. doi:10.1097/BOR.0000000000000555.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/BOR.0000000000000555</ArticleId>
            <ArticleId IdType="pubmed">30239350</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Witt LJ, Curran JJ, Strek ME. The diagnosis and treatment of antisynthetase syndrome. Clin Pulm Med. 2016;23(5):218–226. doi:10.1097/CPM.0000000000000171.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/CPM.0000000000000171</ArticleId>
            <ArticleId IdType="pmc">PMC5006392</ArticleId>
            <ArticleId IdType="pubmed">27594777</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maturu VN, Lakshman A, Bal A, et al. . 
Antisynthetase syndrome: an under-recognized cause of interstitial lung disease. Lung India. 2016;33(1):20–26. doi:10.4103/0970-2113.173055.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4103/0970-2113.173055</ArticleId>
            <ArticleId IdType="pmc">PMC4748659</ArticleId>
            <ArticleId IdType="pubmed">26933302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marguerie C, Bunn CC, Beynon HLC, et al. . 
Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med. 1990;77(1):1019–1038. doi:10.1093/qjmed/77.1.1019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/qjmed/77.1.1019</ArticleId>
            <ArticleId IdType="pubmed">2267280</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rüegg CA, Maurer B, Laube I, Scholtze D. Jo1-antisynthetase syndrome and severe interstitial lung disease with organising pneumonia on histopathology with favourable outcome on early combined treatment with corticosteroids, mycophenolate mofetil and rituximab. BMJ Case Rep. 2019;12(9):e231006. doi:10.1136/bcr-2019-231006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bcr-2019-231006</ArticleId>
            <ArticleId IdType="pmc">PMC6747926</ArticleId>
            <ArticleId IdType="pubmed">31519721</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lega J-C, Fabien N, Reynaud Q, et al. . 
The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome. Autoimmun Rev. 2014;13(9):883–891. doi:10.1016/j.autrev.2014.03.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.autrev.2014.03.004</ArticleId>
            <ArticleId IdType="pubmed">24704867</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Richardson C, Haque UJ. Pulmonary capillaritis in a patient with antisynthetase syndrome and anti-PL-7 antibodies. J Clin Rheumatol. 2019;25(6):e91–e92. doi:10.1097/RHU.0000000000000746.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/RHU.0000000000000746</ArticleId>
            <ArticleId IdType="pmc">PMC6215745</ArticleId>
            <ArticleId IdType="pubmed">29742539</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vargas-Gutiérrez DA, Solís-Jiménez F, Arias Callejas KI, et al. . 
Diffuse alveolar hemorrhage in a patient with antisynthetase syndrome. Case Rep Rheumatol. 2019;2019:1–4. doi:10.1155/2019/5453717.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2019/5453717</ArticleId>
            <ArticleId IdType="pmc">PMC6701415</ArticleId>
            <ArticleId IdType="pubmed">31467762</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Priyangika S, Karunarathna W, Liyanage I, et al. . 
Organizing pneumonia as the first manifestation of anti-synthetase syndrome. BMC Res Notes. 2016;9(1):290. doi:10.1186/s13104-016-2094-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13104-016-2094-3</ArticleId>
            <ArticleId IdType="pmc">PMC4890335</ArticleId>
            <ArticleId IdType="pubmed">27251562</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Svensson J, Holmqvist M, Lundberg IE, Arkema EV. Infections and respiratory tract disease as risk factors for idiopathic inflammatory myopathies: a population-based case-control study. Ann Rheum Dis. 2017;76(11):1803–1808. doi:10.1136/annrheumdis-2017-211174.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/annrheumdis-2017-211174</ArticleId>
            <ArticleId IdType="pubmed">28855175</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Casciola-Rosen L, Andrade F, Ulanet D, Wong WB, Rosen A. Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J Exp Med. 1999;190(6):815–826. doi:10.1084/jem.190.6.815.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.190.6.815</ArticleId>
            <ArticleId IdType="pmc">PMC2195625</ArticleId>
            <ArticleId IdType="pubmed">10499920</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Connors GR, Christopher-Stine L, Oddis CV, Danoff SK. Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?
Chest. 2010;138(6):1464–1474. doi:10.1378/chest.10-0180.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.10-0180</ArticleId>
            <ArticleId IdType="pubmed">21138882</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Solomon J, Swigris JJ, Brown KK. Myositis-related interstitial lung disease and antisynthetase syndrome. J Bras Pneumol. 2011;37(1):100–109. doi:10.1590/S1806-37132011000100015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/S1806-37132011000100015</ArticleId>
            <ArticleId IdType="pmc">PMC3676869</ArticleId>
            <ArticleId IdType="pubmed">21390438</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stone KB, Oddis CV, Fertig N, et al. . 
Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy. Arthritis Rheum. 2007;56(9):3125–3131. doi:10.1002/art.22865.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/art.22865</ArticleId>
            <ArticleId IdType="pubmed">17763431</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
